Notice2024-02255
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 6, 2024
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 25 (Tuesday, February 6, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Page 8246]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02255]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on January 9, 2024, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology
Enterprise Consortium (``MTEC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, Act Medical, Ltd., Loughborough, GREAT
BRITIAN; Affinity Associates LLC, Holden Beach, NC; Akthelia,
Reykjavik, ICELAND; Altra, Inc., Las Vegas, NV; Amazon Web Services,
Arlington, VA; AutoMedicus Corp., Pasadena, CA; AutonomUS Medical
Technologies, Inc., Cambridge, MA; Collabralink Technologies, Inc., dba
Groundswell, McLean, VA; Compression Works, Inc., Birmingham, AL;
Convergent Clinical, Inc., Carlsbad, CA; DesiCorp, Inc., Louisville,
KY; Digital Velocity Partners LLC, Chevy Chase, MD; Duquesne University
of the Holy Spirit, Pittsburgh, PA; E4 Technology, Inc., Huntsville,
AL; Elemance LLC, Winston Salem, NC; Endpoint Health, Palo Alto, CA;
Epineuron Technologies, Inc., Mississauga, CANADA; First Nation Group
LLC, Niceville, FL; Fistula Solution Corp., Scandia, MN; Global
Resonance Technologies LLC, Shelburne, VT; Grande Delta Corp., Alameda,
CA; GrayMatters Health Ltd., Haifa, ISRAEL; Halomine, Inc., Ithaca, NY;
International Scientific Advisors, Inc. dba MilMed Connect, Beaverton,
OR; JDSAT, Inc., Mclean, VA; JLM ExoGrade LLC, Austin, TX;
KardioGenics, Inc., San Jose, CA; Legacy US, Inc., Boise, ID; Longhorn
Vaccines and Diagnostics LLC, Bethesda, MD; Longhorn Vaccines and
Diagnostics LLC, Bethesda, MD; MedStar Health Research Institute, Inc.,
Hyattsville, MD; Muscle Activation Techniques, Englewood, CO; Nuream,
Inc., Wilmington, NC; NZ Technologies, Inc., Vancouver, CANADA; Padagis
US LLC, Allegan, MI; Physcient Surgical, Inc., Durham, NC; Powerboard
Life Systems, Inc., San Francisco, CA; ppx-TEC LLC, Jackson, MS; RedC
Biotech, Ltd., Bnei Zion, ISRAEL; RESDEF, Inc., Chicago, IL; Sigma
Genetics, Inc. Seattle, WA; Soar Technology LLC, Ann Arbor, MI; Sperry
Bio, Inc., Springfield, VT; Sterogene Bioseparations, Inc., Carlsbad,
CA; Sutton's Creek, Westlake, CA; Syracuse University, Syracuse, NY;
Tachmed, Inc., New York, NY; Texas Christian University, Fort Worth,
TX; The Huntsman Mental Health Foundation, Salt Lake City, UT; Turner
Imaging Systems, Orem, UT; University of Alabama, Huntsville,
Huntsville, AL; University of Chicago, Chicago, IL; University of Texas
Southwestern Medical Center, Dallas, TX; Vascarta Inc., Short Hills,
NJ; Vaxart, Inc., South San Francisco, CA; Vaxxas, Cambridge, MA;
Verndari, Inc., Rancho, Cordova, CA; Vigor Medical Technologies, Ltd.,
Haifa, ISRAEL; Virpax Pharmaceuticals, Inc., Berwyn, PA; Vivosang,
Inc., Santa Fe, NM; and Xtory, Inc., Arlington, MA, have been added as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on October 2,
2023. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on December 15, 2023 (88 FR 86932).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-02255 Filed 2-5-24; 8:45 am]
BILLING CODE
</pre></body>
</html>Indexed from Federal Register on February 6, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.